Section 5 of 6
Conclusions
Isabel Blancas, Miriam González de la Peña, María Fernández Abad, Silvia Antolín Novoa, Encarna Adrover Cebrián, Rodrigo Sánchez Bayona, Esther Zamora Adelantado, Raquel Andrés Conejero, Sonia del Barco Berrón, Manuel Atienza, Alberto Molero, Silvia Díaz-Cerezo, Clara Pérez-Rambla, F. J. Pérez-Sádaba, and Luis Manso · about 1 minutes
The present study highlights the clinical value of PSPs in the context of abemaciclib treatment. Episodes of diarrhea were mostly mild (grade 1–2), and no patients had to discontinue treatment due to this adverse event. Patients reported high satisfaction with the PSP, good adherence, and favorable quality of life, supporting the integration of the PSP in clinical practice. Therefore, programs offering nutritional and adverse event management recommendations can be valuable in improving patient care and preventing treatment discontinuation. These findings may inform the broader implementation of PSPs across clinical settings and contribute to future oncology care strategies.